Breast cancer is a heterogeneous disease with various molecular subtypes, including hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC) (2).Traditional treatment methods include surgery, radiotherapy, chemotherapy, and endocrine therapy (3). This evidence concerns the gene HR and triple-negative breast carcinoma.